Skip to main content
Fig. 8 | Arthritis Research & Therapy

Fig. 8

From: Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils

Fig. 8

Janus kinase 2/signal transducer and activation of transcription 3 (JAK2/STAT3) phosphorylation in granulocyte–macrophage colony-stimulating factor (GM-CSF)-stimulated neutrophils. Neutrophils from a healthy subject and a patient with rheumatoid arthritis (RA) were pretreated with tofacitinib for 30 min and then stimulated with GM-CSF (10 ng/mL) for 20 min. Cellular lysates were subjected to Western blot using anti-phospho JAK2 or anti-phospho STAT3 antibodies. Data are representative of three independent experiments

Back to article page